Data Management 365
Data Management 365
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, familial Mediterranean fever, hereditary disease, hereditary periodic fever syndrome | Recruiting | Phase 2 | 2024-12-16 | NCT05190991 | |
| Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, familial Mediterranean fever, hereditary disease, hereditary periodic fever syndrome | Active, not recruiting | Phase 2 | 2024-12-06 | NCT05092776 | |
| Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases | interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2024-11-19 | NCT06440746 | |
| Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis | cardiovascular disorder, heart disorder, idiopathic recurrent pericarditis, pericarditis | Active, not recruiting | Phase 3 | 2024-11-15 | NCT05673902 |